chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two hours after 2nd dose, I was suddenly struck with double vision.  Went to doctor and received highest power of prism in right glasses lens.  Had a 3 scan MRI in which nothing showed up as to a reason for double vision. Scheduled for eye surgery to realign my eyes on November 18. (My family nor I have ever experienced double vision before.)
arm soreness; headache; fatigue; This is a spontaneous report from a contactable consumer (patient). A 65-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 12Jan2021 09:00 at a single dose in the left arm for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no COVID prior to vaccination. The patient had no other vaccine in four weeks. On 12Jan2021, the patient experienced arm soreness, headache, and fatigue. No treatments received in response to the events reported. The patient was not tested for COVID post vaccination. The patient recovered from the events arm soreness, headache, and fatigue in Jan2021.   Information about Lot/Batch number is requested.
Severe headache; Soreness at the injection site; Could not stand, walk, or get out of bed; Could not stand, walk, or get out of bed; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via an unspecified route of administration in the left arm on 28Apr2021 at 11:45 (at the age of 57-years-old) as a single dose for COVID -19 immunisation. Medical history included bipolar disorder, possible neuropathy. The patient had known allergies to sulpha drugs. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Unknown), via an unspecified route of administration in the left arm on 07Apr2021 at 11:45 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Apr2021 at 08:00, the patient could not stand, walk, or get out of bed. Shot received around Noon on 28Apr. The patient had to be carried to and from bathroom etc until 30Apr2021 around 18:00. Additionally the patient had a severe headache and soreness at the injection site. The reaction was horrible and she was fully incapacitated. The clinical outcomes of could not stand, walk, or get out of bed was recovered on 30Apr2021 at 18:00 and severe headache, soreness at the injection site were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
COVID-19; COVID-19; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for 28 patients. This is one of 28 reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced COVID-19 (medically significant) on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on unknown date. The reporter stated that 28 people from a certain educational facility tested positive.  The lot number for bnt162b2 was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : PFIZER INC-202101237061 Same reporter/product/events, different patient
this patient was given afluria which is only to be give to 18 and older. no reaction. I-92579218 and I-92318744
This spontaneous report was received from a registered nurse referring to a patient of unknown age. Information about drug reactions/allergies, concomitant medication and medical history was not provided. On an unknown date the patient was administered an improperly stored dose of PEDVAXHIB (lot # N024571, expiration date 01-MAY-2020) intramuscularly for prophylaxis. No adverse effects reported. The outcome of the events was unknown.
sharp pain when breathing in from 10am till about 2pm. Also, compliants of fatique, arm pain, and nausea
diaphoresis, hypotention, bradycardia, dizzy. likely vasovagal/presyncope 2/2 seeing blood after admin of vaccine
after 2nd vaccine; 1 week plantar wart right foot 99% gone/The plantar wart is totally gone; sore left arm for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (after 2nd vaccine; 1 week plantar wart right foot 99% gone/The plantar wart is totally gone) and PAIN IN EXTREMITY (sore left arm for 2 days) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (after 2nd vaccine; 1 week plantar wart right foot 99% gone/The plantar wart is totally gone). 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore left arm for 2 days). On 17-Apr-2021, PAIN IN EXTREMITY (sore left arm for 2 days) had resolved. At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (after 2nd vaccine; 1 week plantar wart right foot 99% gone/The plantar wart is totally gone) had resolved.            No treatment medication was provided.  No concomitant medication was provided.
DTAP inadvertently given at the age of 8 instead of Tdap. No known reaction occurred.
Pt. was given H1N1 shot on 1/26/2010 at about 3 PM. The following day 1/27/2010, pt. woke up with a temp, sore throat and cough, headache. 1/28/2010 pt woke up with conjunctivitis.
Individual symptomatic with fever/chills, body aches, and cough since 12/13/21. She reported positive Covid results on 12/14/21. Husband tested positive too on the same day. Both are isolating together. Isolation period until 12/23/21. Individual will callback for further guidance. Antibody testing ordered.
Rash & h/a began 15AUG92 recvd MMR 14AUG92; rash is flat bumpy on abdomen only continues today on abdomen only; h/a are relieved by Ibuproten;
3:00 shot given 3:05 stomach pains and headache (for 16 hours) Monday 7am joint aches and pains  Tuesday aches improved Next Tuesday March 23  bad headaches and calf cramps which has lasted for 3 weeks. She also has a pain up the left side of her neck that runs into the base of her brain. It is a daily problem. Currently still having problems.
woke up early this morning feeling sharp as a tack; This is a spontaneous report.    A contactable consumer (Patients daughter) reported for her father that a male patient of unspecified age received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history included dementia. Concomitant medications were not reported. The patient previously received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. On an unspecified date, the patient experienced woke up early this morning feeling sharp as a tack. Her dad just got his second Pfizer shot yesterday and he had no side effects. He had early dementia and he woke up early this morning feeling sharp as a tack, feeling great. He was awesome. No swelling. No soreness in the arm yesterday and it was like wow. Every single person she knew was flat out in some way. Well praise the lord because that was what he needed. Outcome of the event was unknown.  Information about batch/lot number has been requested.
Experienced significant fatigue, muscle aches, headaches for a full week after receiving the COVID19 bivalent shot and the flu shot. About 8 days after receiving the shots, I had an episode of symptomatic paroxysmal atrial fibrillation at about 02:00 on October 2, 2022.  My symptoms were feeling out of breath when normal activities (climbing stairs) and some lightheadedness. I went to the emergency department. later that morning for treatment and they confirm the arrhythmia and performed an electrical cardioversion that morning to return me to normal sinus rhythm. I returned home that day and followed up with a cardiac electrophysiologist on 10/5/22.
dark, orange colored urine.; This spontaneous case was reported by a consumer and describes the occurrence of CHROMATURIA (dark, orange colored urine.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced CHROMATURIA (dark, orange colored urine.). At the time of the report, CHROMATURIA (dark, orange colored urine.) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact
Patient c/o n/v; emesis x2 unwitness; faced flushed skin diaphoretic and hot to touch. Assessed on scene; patient alert and orient x 3; MAEW ambulates with assist to "sick room". Provided Saltine crackers, Sprite and H2O, cool compress to neck. Patient reports decrease in symptoms.
severe pain; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer of an unspecified age (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date, the patient experienced severe pain. The patient specified that she was due to get second dose next Friday but she was in severe pain because both shoulders need to get replaced. The patient asked how long until she can take steroid injections and how safe was to travel after getting the vaccine. The outcome of the event was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Left arm was sore for 24 hours after injection. Ten days later the left arm became sore again. There was tingling in my lower face.  Each day since February 10, there has been some degree of numb/tingling feeling in my lower  face.  There have been numb/tingling feelings in my left arm and hand, but also at times in  both legs, and occasionally in my right arm. This has been going on for several weeks now.
Client stated she had a reaction after getting a Rabies shot in ER. Reaction started 2 minutes after shots given. Benadryl given. Symptoms-swollen feet, legs and slight rash. Symptoms subsided 1 hour after Benadryl taken. Client and her 4 children also received Gamma globulin.
Patient was vaccinated on 3/18/21.  1 to 2 weeks later patient reported fatigue and general malaise.  Reported to PCP.  PCP obtained CMP, CBC with differential.  Patient was found to be hyponatremic with a serum sodium level of 110.  Patient was admitted to hospital on 4.12.21.  Workup showed that patient was in AKI and had DVT.  Patient was treated with 3% sodium chloride infusion and was given diuretics.  AKI resolved through his course of admission.  Patient was treated with enoxaparin for DVT.
This case was reported by a consumer and described the occurrence of swelling arm in a 71-year-old female patient who received BOOSTRIX. Previously administered products included Flu vaccine (swelling arm, pain, redness and warmth at the injection site). On 23rd April 2015 13:00, the patient received BOOSTRIX. On 25th April 2015, 2 days after receiving BOOSTRIX, the patient experienced swelling arm, injection site warmth, injection site erythema and injection site pain. On 27th April 2015, the patient experienced tingling of extremity and numbness of upper extremities. On an unknown date, the outcome of the swelling arm and injection site pain were recovering/resolving and the outcome of the injection site warmth, tingling of extremity and numbness of upper extremities were unknown and the outcome of the injection site erythema was recovered/resolved. The reporter considered the swelling arm, injection site erythema, injection site pain, tingling of extremity and numbness of upper extremities to be almost certainly related to BOOSTRIX. It was unknown if the reporter considered the injection site warmth to be related to BOOSTRIX. Additional information: The caller reports she received a BOOSTRIX vaccine last Thursday. She reports on Saturday her arm started to swell, there was redness at the injection site, and she experienced pain as well. She reports she tried to exercise this morning and her arm started to tingle and it felt like it was going to sleep. She reports she had a flu vaccine about 8-10 years ago, manufacturer unknown and her arm started to swell up, the injection site was red and in pain, and it felt hot at the injection site after she received that vaccine. She has recovered from those events. She reports she received another flu shot about 6 months after the first flu shot. The doctor divided this second flu shot into 1/5th of the actual dose so he could try and mitigate any reactions to the shot itself. However, the same events occurred with this reduced flu shot dose.
pt was nervous about getting covid 19 vaccine before entering store and after vaccine she said her heart felt like it was beating strongly and her vision was blurred she got extremely warm to touch and clamie skin she was "tingeling" felt weird
This is a spontaneous report from a contactable consumer based on information received by Pfizer from Amgen (manufacturer control number US-AMGEN-USASP2017088236), license party for ENBREL. Initial Receipt Date = 08/JUN/2017. This serious spontaneous report (USASP2017088236) was reported to Amgen on 08/JUN/2017 by a consumer and involves a 56 years old female patient who was experiencing joint pain all over her body while receiving ENBREL. No historical medical condition was reported. The patient's current medical condition included rheumatoid arthritis. No concomitant medications were reported. The patient's co-suspect medications included PREVNAR 13. The patient began ENBREL on an unknown date in 2015, approximately two years prior to this report. On an unknown date, the patient stated that she went to her primary care physician and received the PREVNAR 13 Vaccine. Subsequently, the patient was experiencing joint pain all over her body. On 08/JUN/2017 on the day of  this report, the patient was due for her dose. No treatment information was received. The outcome of the event rheumatoid arthritis was reported as unknown. Action taken with ENBREL was continued for the event rheumatoid arthritis. The causal relationship between the event rheumatoid arthritis and ENBREL was not provided by the consumer. The reporter declined consent for follow up. Amgen comment:This safety report does not necessarily reflect a conclusion by Amgen that etanercept, caused or contributed to the adverse event reported; however, consistent with regulatory reporting requirements, this case is being reported because it contains one or more suspected adverse reactions. This individual case report does not change the safety profile of the product.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PAIN (arm soreness), VACCINATION SITE PRURITUS (arm itching), VACCINATION SITE ERYTHEMA (bright red area about 2.5 inches in diameter) and RASH (tiny little bumps/bumps on her chest, neck,) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032I20a) for COVID-19 vaccination. Concurrent medical conditions included Prickly heat. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm soreness). On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (arm itching). On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE ERYTHEMA (bright red area about 2.5 inches in diameter) and RASH (tiny little bumps/bumps on her chest, neck,). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. In February 2021, VACCINATION SITE PAIN (arm soreness) had resolved. At the time of the report, VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (arm itching) and VACCINATION SITE ERYTHEMA (bright red area about 2.5 inches in diameter) outcome was unknown and RASH (tiny little bumps/bumps on her chest, neck,) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information also included antibacterial soap. No concomitant medication was provided.
Pt had grand mal sz w/in 12hrs of DTP shot; no prior sx hx; sx's cont daily (myoclonic w/occasional tonic-clonic sz about every 2 wks; sz's currently controlled w/Depakene;
Hypertensive crisis at 180/95; Vascular thrombosis; Head is spinning; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6198), via an unspecified route of administration in left arm, on 16Mar2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. In Mar2021, the patient's head was spinning, there was a hypertensive crisis at 180/95 for 2 times, and there may be a vascular thrombosis. It was unknown if treatment was received for the adverse events. The events were considered non-serious by the patient. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown.
Received vaccine on 1/11/2021, the next day patient started with chills, arm redness, warmth at site, just did not feel good
there were no adverse events, although patient tested + for COVID on 8/26/21 after 2 doses.  This event is being reported b/c the patient received a third COVID vaccination in error on 8/31/21, after receiving Regen-COV on 8/28/21.  Third vaccine dose given was Pfizer lot #FC3180 given in left deltoid.
Had headache the first 2 days following the shot. On the third day, I was extremely dizzy, light-headed, and nauseous. Symptoms improved each day. I received the shot on 12.16.2021. As of 12.22.2021 I still feel slightly dizzy and nauseous.
Patient stated that one week after getting the vaccination he feels like he has a burning sensation (ants crawling) in his neck. Its worse at bedtime.
arm pain within 1st hour which lasted by weekend; size of her arm got bigger than other arm; under arm lymph node of same arm got swollen; rash on her bicep where injection was administered/rash spread down to her elbow; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm pain within 1st hour which lasted by weekend), PERIPHERAL SWELLING (size of her arm got bigger than other arm), LYMPHADENOPATHY (under arm lymph node of same arm got swollen) and VACCINATION SITE RASH (rash on her bicep where injection was administered/rash spread down to her elbow) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Suspected COVID-19 (suspects that she had covid in the past). Concurrent medical conditions included Food allergy (was allergic to some foods when she was a kid).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain within 1st hour which lasted by weekend), PERIPHERAL SWELLING (size of her arm got bigger than other arm), LYMPHADENOPATHY (under arm lymph node of same arm got swollen) and VACCINATION SITE RASH (rash on her bicep where injection was administered/rash spread down to her elbow). The patient was treated with CORTISONE at a dose of shot. At the time of the report, PAIN IN EXTREMITY (arm pain within 1st hour which lasted by weekend) had resolved and PERIPHERAL SWELLING (size of her arm got bigger than other arm), LYMPHADENOPATHY (under arm lymph node of same arm got swollen) and VACCINATION SITE RASH (rash on her bicep where injection was administered/rash spread down to her elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. Patient was given a cortisone shot on her second visit to urgent care which made her feel better.The patient received additional treatment with unspecified topical creams and ice pack. Patient is scheduled for 2nd dose on 17-APR-2021.
Ems called. Pt decided at 0830 did not want to be evaluated and left vaccination site. States if she felt bad again would go to er to be evaluated.